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Abstract: Expanding access to antiretroviral therapy (ART) has both individual health benefits and potential to decrease 
HIV incidence. Ensuring access to HIV services is a significant human rights issue and successful programmes require 
adequate human rights protections and community support. However, the cost of specific human rights and community 
support interventions for equitable, sustainable and non-discriminatory access to ART are not well described. Human 
rights and community support interventions were identified using the literature and through consultations with experts. 
Specific costs were then determined for these health sector interventions. Population and epidemic data were provided 
through the Statistics South Africa 2009 national mid-year estimates. Costs of scale up of HIV prevention and treatment 
were taken from recently published estimates. Interventions addressed access to services, minimising stigma and 
discrimination against people living with HIV, confidentiality, informed consent and counselling quality. Integrated HIV 
programme interventions included training for counsellors, ‘Know Your Rights’ information desks, outreach campaigns 
for most at risk populations, and adherence support. Complementary measures included post-service interviews, human 
rights abuse monitoring, transportation costs, legal assistance, and funding for human rights and community support 
organisations. Other essential non-health sector interventions were identified but not included in the costing framework. 
The annual costs for the human rights and community support interventions are United States (US) $63.8 million (US 
$1.22 per capita), representing 1.5% of total health sector HIV programme costs. Respect for human rights and 
community engagement can be understood both as an obligation of expanded ART programmes and as a critically 
important factor in their success. Basic rights-based and community support interventions constitute only a small 
percentage of overall programmes costs. ART programs should consider measuring the cost and impact of human rights 
and community support interventions as key aspects of successful programme expansion. 
Keywords: Cost analysis, economics, HAART, highly active antiretroviral therapy, HIV prevention, human rights. 
INTRODUCTION 
 In 2010, an estimated 34 million people were living with 
HIV and the majority of people with HIV were living in low- 
and middle-income countries [1,2,3]. This disproportionate 
HIV burden is often compounded by the lack of quality 
prevention, testing and treatment services. After the G8 
commitment in 2005, all United Nations member states 
pledged to achieve universal access to quality HIV 
prevention, testing and treatment by 2010 [4, 5]. This builds 
on the 2003 ‘3 by 5’ initiative, the broader Millennium 
Development Goals (MDGs) [6] and the 2010 push for 
treatment optimisation through the World Health  
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Organization (WHO)/Joint United Nations Programme on 
HIV/AIDS (UNAIDS) Treatment 2.0 platform [7]. These 
efforts reflect the international community’s commitment to 
combat HIV/AIDS and recognise human rights as “an 
essential element in the global response to the HIV/AIDS 
pandemic” [8]. 
 UNAIDS estimated that by the end of 2010 6.6 million 
people were taking antiretroviral therapy (ART), around 
42% of those in need as defined by the 2010 WHO 
recommendations for ART for those with CD4 cell count < 
350 cells/mm3 [1,2,3]. Despite this achievement, around 9 
million people were estimated to be eligible and still in need 
of treatment in 2010, with substantial patient attrition along 
the treatment cascade from HIV testing and staging to ART 
initiation and continuation [1,3,9,10,11]. Furthermore, only 
around 40% of people living with HIV know their status and 
the number of new infections continues to add to the future 
caseload, with around 2.6 million new infections estimated 
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in 2010 alone [1, 3, 12]. Moreover, virtually everyone with 
HIV will eventually need ART to survive so as many as 28 
million people are waiting, mostly without knowing that they 
are living with HIV, to become ART-eligible before they 
sicken or die [1, 2]. 
 The concept of expanding access to ART is integral to 
the human right to health and provides a significant benefit 
for individuals and the community. However, in some 
settings, human rights abuses have been reported in 
association with HIV testing and counselling and treatment 
programmes [14-16]. It is essential to improve and expand 
approaches which increase access to HIV testing and 
treatment while ensuring respect for and protection of human 
rights. This is not only an ethical obligation of HIV 
programmes, but also critical to increased uptake of HIV 
testing, counselling and treatment, reducing vulnerability to 
infection and ensuring the success of ART expansion. 
 The basic human right to health care including HIV 
services remains a major human rights shortfall in most parts 
of the world. Human rights advocacy has emphasised how 
human rights abuses increase vulnerability to HIV infection 
and impede effective HIV responses [8, 17]. Other HIV-
related human rights abuses have been widely reported, 
including those related to access to accurate and 
comprehensive HIV prevention and treatment information 
[18,19], HIV testing [16], equitable access to treatment for 
criminalised populations and prisoners [20-24], men who 
have sex with men [25], migrants [26, 27], women [28-30], 
and children [31-33]. People living with HIV have been 
subject to violations of human rights on the basis of their 
HIV status, including lack of access to care, experiencing 
stigma and discrimination, loss of property, employment, 
freedom and health. There is a clear intersection between the 
right to health and the realisation of other human rights. For 
example, gender inequality and entrenched discrimination on 
the basis of sexual orientation not only undercut mental and 
physical health status, but also hinder access to prevention 
and treatment programmes, thus increasing individual and 
community vulnerability to HIV. There are increasing calls 
for human rights and community-support specific planning 
and funding as an integral element of efforts to reach 
universal access to high quality HIV services [34]. Despite 
this growing recognition, these interventions are rarely 
costed or included in HIV programming to improve access 
and health outcomes. 
 Ensuring access to high quality ART requires community 
engagement within a strong human rights framework. To 
examine the potential costs of integrating human rights and 
community support into routine programming, we 
constructed a detailed hypothetical costing framework using 
South Africa’s health infrastructure [35]. We considered 
both integrated and complementary health sector 
interventions. Although we identified them, we did not 
include non-health sector costs in the costing framework 
(Table 1). Ultimately, a successful response to the HIV 
epidemic would also require non-health sector human rights 
interventions to address broader socio-economic issues 
beyond the narrow health sector. 
 
 
Table 1. Selected Non-Health Sector Human Rights and 
Community Support Interventions Not Included in 
the Costing Framework 
 
Legal reform 
-civil and criminal code 
-law enforcement 
-correctional system 
Changing cultural norms 
-equal rights for women and vulnerable populations 
-preventing violence against women and children and other vulnerable 
populations 
-engaging religious community engaging religious community for human 
rights and community support  
Addressing socioeconomic environment 
-poverty reduction 
-economic development 
-improve employment opportunities and conditions 
Improving educational system 
-primary, secondary and higher education 
-health care providers pre-service training 
Multi-sector civil society support 
-support for civil society, human rights and community support 
organisations 
Strategic information and human rights monitoring 
-regular monitoring and evaluation 
-dissemination of monitoring and evaluation results 
 
METHODS FOR BUILDING THE COSTING 
FRAMEWORK 
 We used a standard search strategy of the published 
literature to determine the human rights and community 
support interventions for the costing framework. We 
consulted experts and key informants regarding published 
and unpublished sources of information. The costing 
framework of the ART programme and the comparison of 
relative costs of the potential human rights and community 
support interventions is based on South African and other 
sub-Saharan data [34] and recently published HIV 
programme cost models [36]. We applied the 80% treatment 
target from the South African National Strategic Plan for 
HIV and AIDS and the WHO recommended eligibility 
criteria of CD4 <350 cells/mm3. In South Africa, the 
projected costs for CD4 200 is United States (US)$58.45 
per capita in 2015 after rapid scale up to 80% coverage, 
compared to US$32.32 in 2008 [37]. We used the WHO 
methodology [2] to estimate the proportions eligible for 
treatment, which for CD4<350 would translate into a 43% 
increase to US $4375 billion over the projected cost for the 
CD4<200 criteria used for the 2015 programme projections 
[36, 38]. Demographic data are taken from government 
publications [38] and we projected the population growth at 
1% per annum in line with the historic trend and the 
published projection of 1.5% per annum annual growth in 
HIV prevalence to 2015 [36]. 
 To reach the 80% treatment target, we included provider-
initiated HIV testing and counselling (PITC) [39], targeted  
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interventions for marginalised groups, and an annual 
community-based campaign in 2909 sites in 9 provinces 
[40]. Costing of the expansion of access to HIV testing and 
counselling included 20% in health care facilities and 80% 
through community-based campaigns. PITC costs were 
derived from routine programme costs and the community 
campaign costs are based on the detailed costing of a 2008 
private-public health campaign in Kenya for which extensive 
and detailed data were available [40, 41]. Kenyan campaign 
costs were adjusted for South Africa in accordance with 
International Monetary Fund (IMF) purchasing power parity 
ratios to align with US dollar treatment costs. 
 Some of the health sector human rights and community 
support interventions were costed as integrated into routine 
HIV services programme scale-up. We also costed additional 
complementary health sector human rights and community 
support interventions that are not routinely considered as part 
of HIV services. Although non-health sector human rights 
interventions, such as the provision of shelter for domestic 
violence survivors, law reform, and other efforts are at the 
core of human rights programming, they were considered 
beyond the scope of this costing exercise which was limited 
to the health sector. A summary diagram demonstrates the 
components of the human rights and community support 
elements included in the costing framework (Fig. 1). 
HUMAN RIGHTS AND COMMUNITY SUPPORT 
INTERVENTIONS 
 Human rights and community support issues, measures to 
address these issues and their associated costs are discussed 
below. In Table 2, specific interventions and the associated 
costs are displayed for each issue identified, including the 
levels at which the intervention is provided (national, 
provincial, district, community; see Fig. 1). Figures showing 
costing breakdown are also included (Fig. 2). 
Improved Access to Health Care 
 Adequate access to health care is an important aspect of 
the basic human right to health [42]. In resource-constrained 
settings, lack of access negatively impacts the control of 
most preventable disease and our ability to improve access 
will likely make the difference between achieving universal 
access and the MDGs [43]. A recent systematic review 
identified the barriers to provision of ART in resource-
limited settings [44], dividing obstacles into economic, 
sociocultural and behavioural. Other reviews have identified 
nutrition, community support, as well as legal and political 
barriers including human rights abuses, as serious obstacles. 
 Economic barriers identified within the scope of the 
costing framework included transportation costs to HIV 
testing and counselling and treatment services [29, 33, 45], 
perceived costs of treatment, testing and counselling [29, 45-
50], and job loss due to HIV positive diagnosis [28, 49]. 
User fees are another common barrier linked to poor 
adherence but are not included in the costing framework 
since we considered public sector service delivery which 
does not include user fees [29, 33, 37]. Marginalised groups 
are particularly vulnerable to HIV and we costed interventions 






















Fig. (1). Schematic diagram showing the human rights measures included in costing according to level of intervention (national, 
provincial, district, site, community). DoH, Department of Health; HR, human rights; BMI, body mass index. 
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Table 2. Summary of Measures to Protect Human Rights and Costs Involved 
 
Measure Level of Intervention Human Rights Issue Targeted Approximate Cost (US$) 




 Stigma and discrimination 
 Barriers to access 
4.6 million per annum  




 Barriers to access including lack of education 
 Consent, confidentiality and counselling 
 Stigma and discrimination 
 Identification and education of women suffering 
domestic violence 
 Needs of marginalised populations 
 Couples/serodiscordant couples specific training 
12.6 million per annum 
Involvement of human rights 
organisations 
National  Development of human rights tools (stigma scales, 
exit poll, training materials for counsellors, training 
materials for law enforcement bodies) 
57,248 per annum 
Independent monitoring and 
evaluation contractor 
 Collate and report on exit 
polls and feedback from site 
staff, counsellors and 
supervisors 
National  Accountability and feedback 150,000 per annum 
Legal assistance 
 Part-time lawyer (1 per 
province, 0.3 of a whole time 
equivalent) 
 Full-time paralegal assistant 
 "Warm line" paging system 
 One-time back-up fund for 
legal representation 
Provincial  Discrimination against HIV positive individuals 
 Consent, confidentiality and counselling 
Lawyer (per province) US 
$7,524 per annum, 
Paralegal assistant (per 
province) US $12,319.  
One-time back-up fund 
(national): US $100,000. 
Human rights provincial 
coordinators 
Provincial  All human rights issues pertaining to expanded 
ART including provider-initiated testing and 
counseling (PITC) 
 
111,353 per annum 
Shelters for women/ 
collaboration with existing 
shelters and support 
organisations 
District  Violence against women Uncosted 
Human rights district 
supervisor 
District  All human rights issues pertaining to expanded 
antiretroviral therapy (ART) including PITC 
652,899 per annum 
Monthly meetings with civil 
societies 
District  Monitoring of human rights abuses 350,600 per annum 
Community support vehicle District  Enable transport of human rights staff for 
monitoring 
797,845 
'Know Your Rights' desk 
 Information 
 Links to support services and 
emergency measures 
Campaign site  Stigma and discrimination 
 Violence against women 
 
673,737 per annum 
PITC brochure costs PITC settings  Stigma and discrimination 
 Violence against women 
261,425 per annum 
Transportation costs Community/provincial  Access to treatment services 
 
9.1 million 
Collaboration with prevention 
of mother-to-child transmission 
programmes and support 
groups for HIV-positive 
pregnant women or mothers 
Community and 
individual 
 Discrimination against HIV-positive pregnant 
women/mothers 
Cost included in 
comprehensive education and 
support package offered and 
in training of counsellors 
Additional measures to support 
most at risk populations 
  Stigma and discrimination Counsellor training, 
part of broader campaign, no 
separate costing 
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access to services. In resource-poor settings, people living 
with HIV may not be able to obtain sufficient nutrition or 
afford travel to seek services [33, 44]. In the absence of 
home-based care or other outreach, people are unlikely to 
seek medical care if costs involved mean forgoing food for 
the sake of travel costs. We included the cost of buses and 
minibuses for transportation to health services for more 
distant parts of the community as well as accessible transport 
for disabled individuals (US $6.9 million per year) and 
nutritional support for those with a body mass index (BMI) 
less than 18 in order to improve health outcomes (US $333 
per person treated, US $64.3 million in South Africa). 
 Additional support at the community level to promote 
adherence to ART has been shown to be effective in some 
settings [51]. Although addressing adherence is complex and 
there may be multiple approaches, potential adherence support 
currently exists in South Africa in the form of tuberculosis 
(TB) directly observed therapy (DOT) workers. DOTS 
workers would require re-orientation to provide adherence 
support for people on ART (not DOT) and would provide an 
important link between HIV and TB services. Table 3 
illustrates selected activities that could be provided by 
community support and human rights workers. In some 
settings, around 70% of incident TB cases have HIV [52] and 
we assumed that there will be a 5% overlap in the numbers of 
community support workers needed. Overall TB DOTS 
workers will provide a small but important level of support 
(5%) for those with HIV associated TB, therefore, we costed 
one community support worker per 120 individuals on ART 
(US $1440 per worker per annum) for the remaining 95% of 
those on treatment. In addition to this, one community support 
supervisor per community site (2909 sites) will be provided 
(US $2667 per community per annum). 
 
Table 3. Examples of Community Support and Human 
Rights Activities 
 
Raising awareness about HIV prevention, treatment and care and 
related stigma and discrimination issues at household and broader 
public levels 
-Home visits 
-Giving talks at community forums (e.g. schools, municipal meetings, 
festivals) 
-Disseminating information 
-Hosting workshops for different target groups (e.g. children, 
adolescents, sex workers, pregnant women, drug users, women and 
girls, men who have sex with men) 
-Liaising with key cultural organisations (e.g., religious community, 
army, political leadership) 
Strengthening community-driven referral system 
-Home visits 
-Clinic attendance and liaison activities 
Community mobilisation 
-Treatment literacy efforts 
-Setting up patient support groups 
-Organising demonstrations 
-Organising campaigns 
HIV prevention and treatment support 
-Male and female condom distribution 
-Dissemination of prevention messaging 
-Treatment literacy and adherence support 
-Hygiene and public health messaging 






(Table 2) contd….. 
Measure Level of 
Intervention 
Human Rights Issue Targeted Approximate Cost (US$) 
Education for women on 




 Violence against women Cost included in promotional and 
educational materials 
Human rights representative Site  All human rights issues pertaining to 
expanded ART including PITC 
Included in Know Your Rights desk 
cost 
Exit poll Site  Accountability, feedback on satisfaction and 
human rights abuses 
673,737 per annum 
Access to phone for 
emergency/helpline calls 
Community  Violence and discrimination against HIV-
positive individuals 
Uncosted (as linked to counselling 
and relevant facilities) 
Community-based adherence 
support  
Community  Support for HIV-positive individuals Human rights/community support 
worker (per 120 HIV+ on treatment): 
USD $1440 per annum for 95% of 
2.3 million people on treatment (total 
cost 26.1 million per annum) 
Human rights/community support 
supervisor (per community): USD 
$2667 per annum for 2909 
communities (total 7.8 million per 
annum). 
Total $33,846,610 
Nutritional support BMI<18 Community  Support for HIV positive individuals 64.3 million (8.3% of those on ART) 
ART, antiretroviral therapy; BMI, body mass index; MTCT, mother-to-child transmission; PITC, provider initiated testing and counselling: US$, United States dollars. 
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 Sociocultural barriers to accessing HIV services 
identified were HIV/AIDS-related stigma and discrimination 
[29-31, 33, 45, 50, 53], gender inequalities [30, 54], cultural  
and social norms leading to marginalisation of certain 
minority groups [20, 25, 44], and those related to health care 
system deficiencies, including poorly trained health care 
providers [45, 46, 54, 55]. Relevant behavioural issues were 
personal denial of illness [46, 49, 56], perception of medical 
testing and care as expensive [45, 46, 48-50], and lack of 
education or awareness of treatment or diagnosis options and 
availability [19, 33, 45, 46, 49, 54, 57-59]. In addition, 
personal factors included refusal to seek medical care unless 
very ill [46, 47, 50], denial of being at risk of infection, 
inability to attend testing due to work or family 
responsibilities, mental health issues [60] and fear of medical 
providers [46]. Although health care worker training and 
communications materials will include discussion of these 
and other issues, specific interventions to address these 
barriers are not costed (see Table 1 for selected non-health 
sector interventions). Expanding access to HIV services 
within a human rights framework may address some of the 
sociocultural barriers as health care workers and the 
community recognize the increasing numbers of people 
accessing HIV testing and counselling and ART. 
 Punitive laws, policies and regulations are common 
barriers to accessing health care worldwide [61], particularly 
for marginalised or criminalised populations [62, 63]. 
According to the 2008 UNAIDS Global Report, 63% of 
countries that reported have laws, regulations, or policies 
that impede access to HIV prevention, treatment, care and 
support among populations most at risk of HIV infection. In 
many parts of the world, legislation effectively criminalises 
populations most at risk of HIV infection, such as sex 
workers, drug users, and men who have sex with men. This 
fuels stigma and discrimination, increases barriers to HIV 
information and treatment, and contributes to the spread of 
the disease. Laws criminalising HIV transmission can 
discourage HIV testing, potentially subjecting those who 
know their HIV status to criminal penalties while exempting 
those who are unaware of their infection [64-67]. Since 
2005, 14 countries in Africa have passed HIV-specific laws 
that potentially criminalise all sexual behaviour among HIV-
positive individuals, including those who use condoms, 
regardless of disclosure and actual risk of transmission. 
More than 80 countries have legislation that prohibits same-
sex behaviour [68]. In a number of countries, maternal-to-
child HIV transmission is a criminal offense, even where 
ART may not be available. 
 Another common issue is work place discrimination, 
resulting in loss of employment, or pre-employment testing 
which prevents people from getting employment in the first 
place. For many people living with HIV, this is the most 
common human rights violation. Although not costed, law 
reform is necessary and will involve capacity building of law 
and policy makers to understand the linkages between rights 
and health, and for the need to remove punitive laws (Table 
1). While recognising the need to address the larger legal and 
social issues, we costed legal assistance in the form of a part-
time lawyer (0.3 full-time equivalent at US $7524 per 
annum) and a full-time paralegal assistant for each province 
(US $12,319). Selection and contracting of the legal support 


















Fig. (2). Estimated annual HIV programme costs and percentages by category with breakdown of human rights and community support 
components (2015).  Care includes pre ART and on ART costs for hospitalization, primary health care, and laboratory. ART includes the 
cost of 1st and 2nd line.  Nutrition is provided to those on ART with BMI<18. Outreach includes campaign- and facility-based HIV testing 
and counselling costs. Nutrition is included in wider programme but not human rights and community support costs. Total human rights 

























422    Current HIV Research, 2011, Vol. 9, No. 6 Jones et al. 
community support organisations. Legal assistance could be 
accessed by a "warm line" paging system, with the existence 
of a one-time back-up fund of US $100,000 for longer-term 
legal representation. We also costed community-based 
“Know Your Rights” campaigns to help build the capacity of 
communities to claim rights and advocate for judicial reform 
including the removal of punitive laws. 
Consent, Counselling and Confidentiality 
 Informed consent and confidentiality of HIV results are 
cornerstones of HIV testing and counselling and clinical 
services [69, 70]. Individuals should be confident that their 
rights will be respected when accessing HIV testing and 
counselling, including their right to decline testing without 
suffering negative consequences, such as the denial of other 
health care [23]. To encourage access to testing while 
respecting rights, it is important that HIV testing is available 
in different settings, and individuals should be able to seek 
testing where they feel most confident that their rights will 
be respected. The framework includes both facility- and 
community-based testing options with the majority of testing 
taking place in the community. PITC is designed to improve 
access to knowing one’s HIV status and is intended to be 
‘opt-out’ (requiring patients to decline routine HIV testing) 
[71-74]. To respect patients’ rights, HIV testing and 
counselling, needs to be both readily available and voluntary 
without coercion and with a fully informed process including 
awareness of the right to refuse. Although most facility-
based and community-based HIV testing is conducted 
without incident, patients may feel unable to refuse a test 
when requested by the health care provider [71-74]. 
Concerns have been raised that provider-initiated testing 
approaches may dissuade people from seeking medical care 
[74, 75]; however, PITC programs have helped to improve 
access to HIV testing and counselling for millions of people 
[76, 77]. ‘Normalising’ HIV testing and counselling, 
including couples counselling, and integrating it with other 
services and community campaign-based approaches may 
assist in minimising the impact of stigma and discrimination 
[78,40]. Improved access to ART, particularly home-based 
ART care, may also lead to a reduction in stigma 
experienced by HIV-positive individuals [79-84]. Health 
care worker education is included in routine training and 
education for all counsellors (campaign- and facility-based 
testing and counselling) and is currently costed at US $12.6 
million per annum. 
 Regardless of the testing venue, obtaining informed 
consent requires that the individual is sufficiently informed 
on a subject to agree to a procedure [69, 70]. In our costing 
framework, information for most clients will be provided 
prior to actual testing by individual briefings by counsellors 
and campaign-based education. People who test positive or 
negative will also require information regarding treatment 
options, support and other interventions to maintain HIV 
negative status [69, 70]. We included resources for human 
rights and community support organisations to monitor HIV 
testing and counselling and work with health care providers 
and patient groups to develop educational materials (cost US 
$261,425). 
 Confidentiality of testing, results and HIV status should 
be  considered as part of routine programme expansion. In 
small communities this may be difficult, with surveys of 
voluntary counselling and testing (VCT) clients 
demonstrating that potential breaches of confidentiality are a 
significant deterrent for uptake of testing [85]. Providing 
different venues for testing and counselling including PITC 
and community-based settings is one potential approach to 
decreasing this potential deterrent. For those that test 
positive, the difficulty of maintaining confidentiality while 
accessing continuing care is also a concern. Costing included 
dissemination of information regarding the facility-based and 
campaign process and the establishment of multiple testing 
sites. The inclusion of youth in community-based HIV 
testing campaigns also requires specific attention [86]. In 
addition to standard training for counsellors, the costing 
includes an additional day of human rights-focussed training 
with a stigma reduction intervention for counsellors (US 
$9.47 million per annum) [87]. Costing included support for 
human rights and community organizations to provide input 
on training and materials relevant to the training of 
counsellors. The 'Know Your Rights Desk,' where 
participants can gather information about human rights and 
support services, includes private counselling space for 
dealing with specific cases in a sensitive and confidential 
manner (US $231.60 per site, US $673,737 per annum for 
2909 sites). 
Monitoring and Evaluation 
 High quality programmes that include a human rights-
based approach are based on accountability [61]. UNAIDS 
and WHO recommend that programmes use monitoring and 
evaluation (M&E) systems to provide timely feedback on 
implementation progress and quality of services [88]. 
Dedicated human rights staff (site-specific human rights and 
community support representative, district supervisors and 
provincial coordinators) as well as human rights bodies 
operating at a national level, need to be engaged in integrated 
M&E activities as well as periodic surveys. The measures 
suggested in this paper are intended to improve the human 
rights framework for successful implementation of ART 
programmess. However, the actual impact of these human 
rights interventions are unknown, and the impact in 
improving quality of services and achieving public health 
and individual health objectives should be measured. In the 
costing framework, district supervisors will be responsible 
for ensuring that the facility HIV testing and counselling and 
community-based campaign are well-implemented from a 
human rights and community-support perspective. Monthly 
meetings between civil society organisations and the district 
supervisor have also been costed. The framework includes 
support for a human rights supervisor for each province (US 
$12,373 per supervisor or US $111,353 per annum for 9 
provinces). District supervisors are costed at US $655,743 
plus US $795,000 for vehicles, while monthly meetings will 
cost US $38,400 per province, US $350,600 per annum. 
Feedback on the services are costed for through exit surveys, 
counsellors, district and site staff, which will require 
collation by an independent M&E contractor and timely 
action on feedback. These potential activities have been 
costed at US $150,000 per annum for the M&E contractor, 
and a further US $673,737 per annum for the exit surveys 
from the 2909 sites. 
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Stigma and Discrimination 
 Although in some settings conditions have improved, it is 
widely recognised that people living with HIV are subject to 
significant stigma and discrimination [89, 90, 91]. Stigma 
and discrimination in turn may lead to reluctance to be 
tested, barriers in seeking testing or health care [44], limited 
uptake of preventive behaviours [92], social isolation and 
ostracism [93], harassment, discriminatory behaviours in 
relation to employment, health care, insurance, ownership of 
property and education, physical violence and anger from 
others, including family members [94]. Human rights and 
community support organisations are costed to adapt and 
develop new monitoring and training tools, including stigma 
scales for people living with HIV, [95, 96] to help health 
care workers in the identification of individuals experiencing 
stigma while accessing expanded HIV services (US $6,361 
per province, US $57,248 per annum). 
Special Needs of Women Living with HIV 
 Women constitute the majority of those infected with 
HIV in sub-Saharan Africa [97] and are often at increased 
risk of becoming HIV infected due to the inability to enforce 
safer sex decisions [98, 99, 100]. This vulnerability is often a 
result of skewed power relations within the relationship 
which can include an inability to negotiate safer sex or leave 
due to economic dependence [101]. Poverty, disruption by 
civil war, spousal death due to HIV, and lack of protective 
policy, laws and enforcement can lead to women being 
forced to resort to survival and transactional sex. Women are 
often more likely to have negative experiences as the result 
of a positive HIV test, including blame for infection, abuse 
or violence from their partner, exclusion from family or 
home and loss of property [29, 30, 102-106]. In anticipation 
of these outcomes, women may refuse testing [107-109]. 
Women may also feel unable to consent for testing without 
explicit consent, or may be prevented from testing by their 
partner [110]. This outlines the need for policy change to 
protect the rights of women to equality, property ownership, 
freedom from abuse and sexual violence, and to realisation 
of health. In integrating a human rights- and community-
based approach, expanding access to human rights and 
community support interventions within the health sector 
response could improve access to life-saving HIV services 
for women. 
 For HIV-positive individuals suffering abuse at the hands 
of an intimate partner, the need for support measures 
including helplines has also been identified [30, 74, 94, 102, 
104, 111]. Support is costed for skills training and protocols 
for counsellors to identify and counsel women who feel at 
risk or have experienced inter-personal violence. Campaign 
and PITC informational materials are intended to educate 
women about domestic violence and inform them of 
available resources, help-lines in South Africa and legal 
rights. Human rights and community support organisations 
are supported within the framework to work with health 
authorities to develop relevant human rights tools and 
protocols (see above). Access to a telephone or other 
communications is assumed to be available at a community 
centre, primary health or HIV treatment facility. 
 Couples and partners counselling has been used as a 
successful prevention intervention [112, 113-115] and a 
criticism of previous testing campaigns has been the lack of 
emphasis on couples-specific counselling [16]. Studies have 
demonstrated the potential of this type of counselling in 
terms of prevention of HIV infection by facilitating status 
disclosure to partners [116, 117]. Couples counselling, by 
providing a safe environment for disclosure, has the potential 
to assist in reducing incidences of domestic violence in 
serodiscordant couples [117]. Pre-campaign social 
mobilisation will stress the benefits of couples testing, and 
the campaign will support couples testing. Costing included 
specific training for counsellors to be better equipped to 
address potential spousal refusal, to assist disclosure of 
status to partners, and to counsel serodiscordant couples 
(included in the overall counsellor training cost of US $9.47 
million above) [117]. 
 As part of a multi-faceted societal response, law 
enforcement agencies must be trained to deal with violence 
directed against women, HIV-positive individuals and 
members of most at risk populations. This matter is out of 
the scope of the costing framework; however, it is 
anticipated that human rights and community support 
organisations will provide advice on the appropriate training 
and materials. 
 Shelters for women have been recognised as a scarce 
resource for which there is great need [118]. Few are offered 
in South Africa, and even fewer have the capacity to care for 
women who are ill [119]. The need for short-term shelters 
for women living with HIV is critical, both for those who 
require medical care and/or those who have suffered 
domestic violence. Although the best outcome is often a 
resolution in which a woman can remain in her community 
with her children, there is also a need for long-term solutions 
for women who can no longer return home. Women’s 
shelters are beyond the scope of health sector 
funding/resources and therefore are not directly costed in the 
model. Collaboration with organisations that advocate 
against violence against women and provide support would 
be needed to successfully implement various components of 
this model. 
Special Needs of Pregnant Women 
 Women who are pregnant face additional barriers. For 
women who test HIV positive, ART is recommended for 
those eligible and antiretrovirals are recommended for others 
to prevent mother-to-child transmission (MTCT) [120]. 
Although potentially life-saving for the mother, the unborn 
child and partners, these interventions increase the likelihood 
of disclosure of a woman's positive HIV status and therefore 
may expose a mother to stigma and discrimination. Support 
services and education are needed for HIV-positive pregnant 
women including follow-up with prevention of MTCT 
programmes, and these would be offered as part of post-test 
counselling [120]. This is currently costed in the framework 
as part of the counselling. 
Special Needs of Most at Risk Populations 
 Although in a generalised epidemic setting people who 
are sexually active are often most at risk, traditional most at 
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risk populations have been more narrowly defined and 
include male and female sex workers, men who have sex 
with men, people who inject drugs, and prisoners. In addition 
to frequently being criminalised and subject to police 
violence [121], it has been reported that only 10% of funding 
for prevention strategies in many countries is allocated to 
key populations [97]. Unless these populations have access 
to legal services, human rights protections including law 
reform and community support services, and funding 
specifically allocated to working with them, it is possible 
that the coverage of the expanded ART programme will be 
poor. Additionally, legal barriers to accessing ART, fragile 
social support networks, transactional partnerships, and high 
levels of stigma impede access to services and may also 
make these populations less likely to disclose their HIV-
positive status to partners [83, 122]. Support is costed to 
access most at risk populations through services in 291 
locations designed and led by community leaders. Costing 
includes counsellor training in issues regarding the needs of 
most at risk populations as part of human rights training day 
(included as part of the US $9.47 million for training for the 
broader community-based outreach). 
Bottom Line: Projecting the Health Sector Costs 
 The public sector costs of expanded access to ART 
including human rights and community support is illustrated 
in Fig. (2). Estimated annual costs for human rights and 
community support for 2015, excluding nutrition are 1.5% 
(US $63.8 million) of the total projected spending on the 
ART programme. Human rights and community support 
costs are divided into those that are population-related 
(counsellors and training), site-related (information and 
monitoring), district-related (implementation, social 
mobilisation and supervision), and province-related 
(management, legal support and independent monitoring). 
Some costs will decrease over time. For example, it is 
assumed that the number of testing site locations will reduce 
from 2909 as the distribution of HIV prevalence falls over 
time. Costs relating to district and province do not vary and 
form 24% of costs at peak, but will rise proportionally over 
time as numbers tested and prevalence decrease. However, 
the costs of nutrition and adherence support are related to 
ART prevalence. Assuming treatment eligibility at 
CD4<350, nutrition cost peaks at US $64.3 million annually. 
LIMITATIONS 
 Attempts to integrate human rights and community 
support into HIV programmes have often been limited to 
vague and often ineffective anti-stigma campaigns that fail to 
adequately address the broad range of human rights abuses. 
In some regards, our attempt to identify and cost public 
sector human rights and community support aspects of 
expanded ART programmes can be seen as replicating this 
overly narrow approach. Yet, while the interventions we 
have identified are limited to the immediate context of 
expanding ART, the identification and costing of these 
interventions can be seen as an important step to ensuring the 
expansion of ART programmes within a human rights-based 
approach. Costing categories are also important for policy 
discussions and decision-making when designing proposals 
and budgets for the expansion of HIV services. Engaging 
with stakeholders to build upon the current model to add 
additional services and costs, including broader “structural-
rights interventions” [61], support for civil society and 
accountability measures will be important next steps in 
furthering models of expanded ART programmes. Although 
our costing categories and costs represent a best estimate 
from the literature, most of the interventions require 
evaluation and research to further develop the scientific 
evidence base regarding them. This is particularly relevant 
with regard to the most appropriate and effective 
interventions to address sociocultural barriers to HIV 
services. While addressing individual behaviours and 
bringing about cultural change is necessary, addressing the 
HIV epidemic is not possible without also addressing 
poverty, underdevelopment and illiteracy [61, 123]. Clearly, 
solutions to these issues involve long-term commitment at 
the international, national and community levels. 
 The costed interventions in this report seek to promote 
the goal of expansion of access to HIV prevention, treatment 
and care, as well as to provide community support and 
protect human rights. To be successful, it is essential that 
rights-based interventions are effective and have a strong 
basis in accountability and community engagement. Costed 
interventions could be implemented in collaboration with 
human rights and community support organisations that 
would optimally use the budget support to lead many of the 
activities. Support is also included for an independent 
auditing body that will provide feedback and a process for 
monitoring and reporting of human rights abuses. 
Collaboration and management of the resources in this 
sensitive area will not be easy and would require flexibility, 
openness and adaptability on all sides, as well as an ability to 
adjust and make improvements. 
CONCLUSION 
 There is increasing scientific evidence supporting the 
expansion of access to ART as part of HIV and TB 
prevention efforts. As part of the exploration of a theoretical 
expanded access to ART public health programme, we 
costed specific measures to ensure community support 
within a human rights-based approach. The programme as a 
whole would improve community access to health care, 
ensuring the basic human right to health. In 2015, the 
estimated human rights and community support programme 
elements totalled US $63.8 million or 1.5% of the projected 
annual budget and included training, education, supervision, 
monitoring and evaluation, transport and adherence support 
costing categories. A further US $64.3 million (1.5% of total 
costs) was added for nutritional support, recognising the 
negative impact of poor nutrition on health status. Although 
the total costs given are dependent upon the size and 
administrative structure of South Africa, many of the costing 
categories could be applied to other low- to middle-income 
settings with appropriate cost adjustments. 
 There are a number of significant challenges to 
implementing human rights and community support. 
Funding for public health is scarce and it is increasingly 
important for stakeholders to dialogue regarding the hard 
choices that are often necessary when deciding on the best 
use of limited resources. Community response and 
engagement in confronting HIV is critical, but communities 
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are often faced with a number of challenges including lack of 
shelter, food and employment. These and other issues are 
likely to directly impact key programme and individual 
objectives such as accessing HIV services, retention, and 
adherence. Additionally, successfully including human rights 
and community support interventions likely requires that all 
parties work within a strong legal framework as well as an 
environment of trust, accountability and understanding—
often the very elements that need to be addressed with 
human rights and community support interventions. 
Establishing a basic costed framework for discussion may 
represent an important step in successfully addressing human 
rights and community support. 
 Human rights in the context of HIV/AIDS has received 
considerable attention. Despite widespread recognition that 
both human rights and community support are essential, 
particularly for a successful response to HIV/AIDS, this 
paper represents one of the first attempts to translate this 
recognition into concrete costed interventions. Clearly 
further dialogue and careful consideration will be necessary 
to refine these potential interventions. Additionally, some of 
the interventions are already being used to improve services, 
and as more of these human rights and community support 
elements are incorporated into HIV programmes, the 
monitoring and evaluation of their impact should add to the 
scientific evidence base and policy discussions. The 
interventions included in the costing framework would 
represent a significant step forward in addressing both the 
HIV epidemic and ensuring a rights-based approach is used. 
However, responsibility for human rights and community 
support extends beyond the health sector, and further wide-
reaching societal change is necessary to ensure that people 
living with HIV receive necessary community support and 
are free from human rights abuses. Although most 
communities have responded admirably to the significant 
challenge of HIV, there is disturbing evidence that 
fundamentally unsound interventions such as criminalisation 
and stigmatisation are gaining ground in some settings. The 
interventions suggested in this paper will likely be most 
successful when combined with social, cultural and political 
interventions to effect lasting and meaningful change, 
requiring commitment by national and international bodies. 
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